Community/Retail

The PQA team is diverse, and they have expertise in quantitative research as well as quality.

These measures are specified for application to pharmacies, as opposed to health plan measures.

Medications are the primary cause of acquired QT-prolongation, although the exact mechanism of why some people evoke torsades de pointes but others do not is still unknown.

Metformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.

Cara McNulty, president of Behavioral Health and Mental Well-Being at CVS Health, discusses a recently published survey from CVS Health Study on rising concerns of mental health in Americans.

Investigators develop a genetic-risk score to identify those who would benefit most from lifestyle counseling to prevent the condition.

Second analysis indicates that parents of children with food allergies became less anxious during the pandemic.

Students in the ISU/UAA pharmacy program discuss the impact of Alaska’s first pharmacy program and what it means to learn about and work in rural communities.

Vedolizumab (Entyvio) is indicated for adult patients with moderately to severely active ulcerative colitis and adult patients with moderately to severely active Crohn disease.

Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

National Asthma and Allergy Awareness Month highlights how pharmacists in all health care settings are in a unique position to improve management and outcomes of individuals with these conditions.

Imposter syndrome is a phenomenon that affects self-confidence, significantly limiting the effectiveness of professionals affected by it.

Analysis shows that half of individuals with both these sensory losses are cognitively impaired, investigators say.

Results from the DELIVER and DAPA-HF phase 3 trials demonstrate AstraZeneca’s Farxiga’s efficacy in heart failure, regardless of ejection fraction.

Individuals who are not vaccinated with pre-existing diabetes, heart artery disease, or high blood pressure had a 2- to 3-fold increased risk of death, investigators say.

In 2019, an article in the Journal of the American College of Clinical Pharmacy encouraged pharmacists to engage professionally on social media, despite their having mostly avoided it for such purposes.

Kank-A Mouth Pain Liquid is for the treatment of canker sore pain and other abrasions inside the mouth.

Spending 1 hour less sitting a day and increasing light physical activity helps prevent diseases, investigators find.

Individuals with college debt have a higher risk of cardiovascular illness, undermining the typical benefits of a post-secondary education, data indicate.

Mavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.

The growth of telehealth during the COVID-19 pandemic has caused health care providers to search for innovative solutions for harder to reach patient populations.

Statistics indicate possible benefit of home-based palliative care interventions, according to study results from the Indiana University School of Medicine and the Regenstrief Institute.

Tea contains flavonoids, which are naturally occurring compounds that have antioxidant properties and provide bioactive compounds that help to neutralize free radicals.

Findings show that key factors include age, infecting variant, underlying illnesses, and vaccination status.

Owning your time and scheduling self check-ins can help students avoid burnout.

FDA action was based on an analysis for the risk of thrombosis with thrombocytopenia syndrome, a rare and potentially life-threatening condition that causes blood clots combined with low levels of blood platelets.

Relief Factor is a supplement that seeks to help users reduce body pains associated with daily living, aging, and exercise.

Even before the COVID-19 pandemic, vaccine hesitancy has been a challenge among adult patient populations.

Analysis results show taking iscosapent ethyl reduces the potential for CV death, coronary revascularization, hospitalization for unstable angina, myocardial infarction, and stroke by 35%.

The companies expect to complete the submission to the FDA for MDD in the first half of 2022 and an associated filing for postpartum depression in 2023.